Dexcom Inc. logo

Dexcom Inc. (DXCM)

Market Closed
6 Mar, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
68. 10
-2.59
-3.66%
$
28.43B Market Cap
134.71 P/E Ratio
- Div Yield
3,930,510 Volume
1.43 Eps
$ 70.69
Previous Close
Day Range
67.64 69.86
Year Range
54.11 89.98
Want to track DXCM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
DXCM earnings report is expected in 47 days (23 Apr 2026)
DexCom, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights - DXCM

DexCom, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights - DXCM

NEW YORK, NY / ACCESSWIRE / August 27, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
Investors Who Lost Money on DexCom, Inc. (DXCM) Should Contact Levi & Korsinsky About Pending Class Action - DXCM

Investors Who Lost Money on DexCom, Inc. (DXCM) Should Contact Levi & Korsinsky About Pending Class Action - DXCM

NEW YORK, NY / ACCESSWIRE / August 27, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
DexCom (DXCM) Accused of Misleading Investors - Hagens Berman

DexCom (DXCM) Accused of Misleading Investors - Hagens Berman

DXCM Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO, CA / ACCESSWIRE / August 27, 2024 / Hagens Berman urges DexCom, Inc. (NASDAQ:DXCM) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys.

Accesswire | 1 year ago
DexCom Stock May Gain on Expanded Reach After Stelo's US Launch

DexCom Stock May Gain on Expanded Reach After Stelo's US Launch

DXCM announces that its OTC CGM, Stelo, is now available for purchase in the United States without a prescription.

Zacks | 1 year ago
DexCom, Inc. Class Action: Levi & Korsinsky Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024 - DXCM

DexCom, Inc. Class Action: Levi & Korsinsky Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024 - DXCM

NEW YORK, NY / ACCESSWIRE / August 27, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 21, 2024 in DexCom, Inc. Lawsuit - DXCM

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 21, 2024 in DexCom, Inc. Lawsuit - DXCM

NEW YORK, NY / ACCESSWIRE / August 27, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
Stockholders In DexCom Inc Should Contact The Schall Law Firm About An Inquiry Into The Company's Potential Securities Fraud

Stockholders In DexCom Inc Should Contact The Schall Law Firm About An Inquiry Into The Company's Potential Securities Fraud

LOS ANGELES, CA / ACCESSWIRE / August 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DexCom, Inc. ("DexCom" or "the Company") (NASDAQ:DXCM) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Accesswire | 1 year ago
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 21, 2024 in DexCom, Inc. Lawsuit - DXCM

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 21, 2024 in DexCom, Inc. Lawsuit - DXCM

NEW YORK, NY / ACCESSWIRE / August 27, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
DXCM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

DXCM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESSWIRE / August 27, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against DexCom, Inc. ("DexCom" or "the Company") (NASDAQ:DXCM) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired DexCom securities between January 8, 2024, and July 25, 2024, inclusive (the "Class Period").

Accesswire | 1 year ago
DexCom, Inc. Class Action: Levi & Korsinsky Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024 - DXCM

DexCom, Inc. Class Action: Levi & Korsinsky Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024 - DXCM

NEW YORK, NY / ACCESSWIRE / August 27, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
DXCM FRAUD ALERT: DexCom, Inc. Investors that Suffered Losses are Notified to Contact BFA Law Before Upcoming October 21 Securities Fraud Deadline (NASDAQ:DXCM)

DXCM FRAUD ALERT: DexCom, Inc. Investors that Suffered Losses are Notified to Contact BFA Law Before Upcoming October 21 Securities Fraud Deadline (NASDAQ:DXCM)

NEW YORK, NY / ACCESSWIRE / August 27, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against DexCom, Inc. (NASDAQ:DXCM) and certain of the Company's senior executives. If you invested in DexCom, you are encouraged to obtain additional information by visiting Click Here

Accesswire | 1 year ago
DexCom, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights - DXCM

DexCom, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights - DXCM

NEW YORK, NY / ACCESSWIRE / August 26, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
Loading...
Load More